Serologic evaluation of human microcystin exposure

Hilborn, ED; Carmichael, WW; Soares, RM; Yuan, M; Servaites, JC; Barton, HA; Azevedo, S

HERO ID

607937

Reference Type

Journal Article

Year

2007

Language

English

PMID

17696142

HERO ID 607937
In Press No
Year 2007
Title Serologic evaluation of human microcystin exposure
Authors Hilborn, ED; Carmichael, WW; Soares, RM; Yuan, M; Servaites, JC; Barton, HA; Azevedo, S
Journal Environmental Toxicology
Volume 22
Issue 5
Page Numbers 459-463
Abstract Microcystins are among the most commonly detected toxins associated with cyanobacteria blooms worldwide. Two episodes of intravenous microcystin exposures occurred among kidney dialysis patients during 1996 and 2001. Analysis of serum samples collected during these episodes suggests that microcystins are detectable as free and bound forms in human serum. Our goal was to characterize the biochemical evidence for human exposure to microcystins, to identify uncertainties associated with interpretation of these observed results, and to identify research needs. We analyzed serum samples using enzyme-linked immunosorbent assay (ELISA) methods to detect free microcystins, and gas chromatography/mass spectrometry (GC/MS) to detect 2-methyl-3-methoxy-4-phenylbutyric acid (MMPB). MMPB is derived from both free and protein-bound microcystins by chemical oxidation, and it appears to represent total microcystins present in serum. We found evidence of free microcystins in patient serum for more than 50 days after the last documented exposure. Serum concentrations of free microcystins were consistently lower than MMPB quantification of total microcystins: free microcystins as measured by ELISA were only 8-51% of total microcystin concentrations as detected by the GC/MS method. After intravenous exposure episodes, we found evidence of microcystins in human serum in free and protein-bound forms, though the nature of the protein-bound forms is uncertain. Free microcystins appear to be a small but variable subset of total microcystins present in human serum. Research is needed to elucidate the human toxicokinetics of microcystins, in part to determine how observed serum concentrations can be used to estimate previous microcystin exposure. (c) 2007 Wiley Periodicals, Inc.
Doi 10.1002/tox.20281
Pmid 17696142
Wosid WOS:000249328800002
Is Certified Translation No
Dupe Override No
Comments Scopus URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548750440&doi=10.1002%2ftox.20281&partnerID=40&md5=5aa62e9b856ee4c99012fcdaae2398c6
Is Public Yes
Language Text English
Keyword 2-methyl-3-methoxy-4- phenylbutyric acid; Human serum; Microcystins; MMPB; Toxicokinetics; 2-methyl-3-methoxy-4- phenylbutyric acid; Enzyme-linked immunosorbent assay (ELISA); Human serum; Microcystins; Toxicokinetics; Algae; Bioassay; Dialysis; Gas chromatography; Mass spectrometry; Oxidation; Toxic materials; 2 methyl 3 methoxy 4 phenylbutyric acid; butyric acid derivative; cyanoginosin; unclassified drug; enzyme activity; gas chromatography; immunoassay; mass spectrometry; oxidation; protein; serum; toxin; article; blood sampling; clinical evaluation; controlled study; environmental exposure; enzyme linked immunosorbent assay; gas chromatography; human; major clinical study; mass spectrometry; oxidation; priority journal; quantitative analysis; renal replacement therapy; serology; toxicokinetics; Bacterial Toxins; Brazil; Environmental Exposure; Humans; Microcystins; Renal Dialysis; Toxemia; Cyanobacteria
Is Qa No